Delivery Order SPE2DB22D2007-SPE2DB24FJ2YV

Award Date 5/30/24
Potential Completion Date 6/21/24
Potential Value $1.8K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award is a delivery order from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $5,578.50, is for the supply of Zoladex 10.8 mg implant syringes. The contract has a firm fixed price pricing type and an ultimate completion date of February 10, 2025. This delivery order is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,631.84, is for the delivery of Zoladex 10.8 mg implant syringes. The contract is a Firm Fixed Price Delivery Order and has an ultimate completion date of July 11, 2024. The contract is not designated as a set-aside. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with...
This is a delivery order contract awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Troop Support Medical. The $1,249.20 firm fixed price contract is for the delivery of the medication Zoladex 3.6 mg implant syringes, with a completion date of November 5, 2024. Amerisourcebergen provides a broad range of pharmaceutical and medical supplies to federal agencies through various Indefinite Delivery Contracts (IDCs), including a...
This federal contract award, valued at $5,263.74, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Zoladex 10.8 mg implant syringes, a specialty medication. The contract has an ultimate completion date of December 4, 2024 and was awarded on November 12, 2024. The contract type is a Delivery Order with a Firm Fixed Price pricing structure. It is not...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of a specialty medication, Zoladex 10.8 mg implant syringes. The contract has a ceiling value of $9,677.52 and was awarded on April 5, 2022, with an ultimate completion date of April 26, 2022. The contract is a firm-fixed-price delivery order, and there is no set-aside designation, indicating open competition. AmerisourceBergen Drug...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor, to supply 4,565,338,778 units of the drug ZOLADEX 10.8 MG IMPLANT SYRNS. The contract has a firm fixed price of $4,386.40 and a completion date of August 23, 2024. This contract is not designated as a set-aside. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued up to $999,999,999 through...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The $7,018.24 Firm Fixed Price Delivery Order is for the supply of the medication Zoladex 10.8 mg Implant Syringes. The contract has an ultimate completion date of May 14, 2024. Amerisourcebergen Drug Corp holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary...
This federal contract award, valued at $1,873.74, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a major pharmaceutical distribution company. The contract is for the delivery of the pharmaceutical product Zoladex 3.6 mg Implant Syringes. This is a firm fixed-price delivery order contract with a completion date of June 3, 2024. The contract was awarded on May 10, 2024 without any set-aside designation....
This federal contract award is for the delivery of the pharmaceutical product Zoladex 10.8 mg implant syringes to the Defense Logistics Agency (DLA) Troop Support Medical. The contract was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, on December 6, 2024, with a potential ceiling value of $5,445.66. The contract has a firm fixed-price delivery order structure and an ultimate completion date of December 30, 2024. AmerisourceBergen...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA). The $21,932 firm fixed-price delivery order is for the supply of ZOLADEX 10.8 MG IMPLANT SYRNS medical devices. The contract has an ultimate completion date of August 13, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a...
  • SPE2DB22D2007
    Indefinite Delivery Contract
  • SPE2DB22D2007-SPE2DB24FJ2YV
    Delivery Order

This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distribution company. The contract is for the supply of the drug Zoladex 10.8 MG Implant Syrinses. The contract is valued at $1,754.58 and has an ultimate completion date of June 21, 2024. It is a Firm Fixed Price contract, meaning the price will not change regardless of the contractor's costs.

AmerisourceBergen Drug Corp holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at up to $999,999,999.00 through December 31, 2025. This IDC serves as the primary vehicle for the company to deliver a wide range of pharmaceutical products and medical supplies to DLA facilities supporting the Department of Defense worldwide. The company also holds a smaller IDC with the Department of Justice Federal Bureau of Investigation for similar medical products and prescription drugs, valued up to $750,000 through May 2024.

This contract does not have a set-aside designation, indicating it was awarded on a full and open competition basis.

Generated 8/29/24, 9:32 AM